Advanced search
Publication Cover
Cancer Investigation Volume 28, 2010 - Issue 8
Submit an article Journal homepage
286
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLECellular and Molecular Biology

Cetuximab Insufficiently Inhibits Glioma Cell Growth Due to Persistent EGFR Downstream Signaling

Benedikte HasselbalchDepartments of Radiation Biology and Oncology, The Finsen Center, Copenhagen University Hospital, Copenhagen, Denmark
,
Ulrik LassenDepartments of Radiation Biology and Oncology, The Finsen Center, Copenhagen University Hospital, Copenhagen, Denmark
,
Hans S. PoulsenDepartments of Radiation Biology and Oncology, The Finsen Center, Copenhagen University Hospital, Copenhagen, DenmarkCorrespondence[email protected]
&
Marie-Thérése StockhausenDepartments of Radiation Biology and Oncology, The Finsen Center, Copenhagen University Hospital, Copenhagen, Denmark
Pages 775-787 | Published online: 26 May 2010

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sabrina Genßler, Michael C. Burger, Congcong Zhang, Sarah Oelsner, Iris Mildenberger, Marlies Wagner, Joachim P. Steinbach & Winfried S. Wels. (2016) Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival. OncoImmunology 5:4.
Read now
Gina Farias-Eisner, Anna M. Bank, Brian Y. Hwang, Geoffrey Appelboom, Matthew A. Piazza, Samuel S. Bruce & E. Sander Connolly. (2012) Glioblastoma biomarkers from bench to bedside: advances and challenges. British Journal of Neurosurgery 26:2, pages 189-194.
Read now

Articles from other publishers (11)

Javier Vaquero, Allan Pavy, Ester Gonzalez-Sanchez, Mark Meredith, Ander Arbelaiz & Laura Fouassier. (2022) Genetic alterations shaping tumor response to anti-EGFR therapies. Drug Resistance Updates 64, pages 100863.
Crossref
Mélanie Gauthier, Caroline Laroye, Danièle Bensoussan, Cédric Boura & Véronique Decot. (2021) Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cells. Critical Reviews in Oncology/Hematology 160, pages 103261.
Crossref
Peter C. Pan & Rajiv S. Magge. (2020) Mechanisms of EGFR Resistance in Glioblastoma. International Journal of Molecular Sciences 21:22, pages 8471.
Crossref
Stephen Lowe, Krishna P. Bhat & Adriana Olar. (2019) Current clinical management of patients with glioblastoma. CANCER REPORTS 2:6.
Crossref
Jakub Litak, Marek Mazurek, Cezary Grochowski, Piotr Kamieniak & Jacek Roliński. (2019) PD-L1/PD-1 Axis in Glioblastoma Multiforme. International Journal of Molecular Sciences 20:21, pages 5347.
Crossref
Stefan Hartmann, Norbert Neckel, Axel Seher, Grit Mutzbauer, Roman C. Brands, Christian Linz, Alexander C. Kübler & Urs D. A. Müller-Richter. (2015) Erlotinib and gefitinib responsiveness in head and neck cancer cell lines—a comparing analysis with cetuximab. Clinical Oral Investigations 20:4, pages 759-769.
Crossref
Henri Wichmann, Antje Güttler, Matthias Bache, Helge Taubert, Swetlana Rot, Jacqueline Kessler, Alexander W. Eckert, Matthias Kappler & Dirk Vordermark. (2014) Targeting of EGFR and HER2 with therapeutic antibodies and siRNAInhibierung von EGFR und HER2 mit therapeutischen Antikörpern und siRNA. Strahlentherapie und Onkologie 191:2, pages 180-191.
Crossref
Adriana Olar & Kenneth D Aldape. (2014) Using the molecular classification of glioblastoma to inform personalized treatment. The Journal of Pathology 232:2, pages 165-177.
Crossref
A. Schulte, K. Liffers, A. Kathagen, S. Riethdorf, S. Zapf, A. Merlo, K. Kolbe, M. Westphal & K. Lamszus. (2013) Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110 . Neuro-Oncology 15:10, pages 1289-1301.
Crossref
Kui Wang, James O. Park & Miqin Zhang. (2013) Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β‐catenin. The Journal of Gene Medicine 15:1, pages 42-50.
Crossref
Egesta Lopci, Arturo Chiti, Maria Rita Castellani, Giovanna Pepe, Lidija Antunovic, Stefano Fanti & Emilio Bombardieri. (2011) Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies. European Journal of Nuclear Medicine and Molecular Imaging 38:S1, pages 28-40.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.